Microarray testing to guide care after liver transplant
Part of Digestive system clinical trials.
This study looks at how special lab tests from tiny tissue samples (microarrays) could help guide diagnosis and treatment in people who receive a liver transplant. It may help doctors better understand what’s going on and choose care more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a liver biopsy done for a medical reason (not just for research).
- You must be able to give informed consent to take part.
- If you are pregnant, you cannot join this study.
- The study team will use your biopsy sample for the microarray-related testing.
- You’ll be asked to confirm participation after reviewing study details.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well noninvasive tests (tests that don’t require surgery or taking tissue) can detect complications after a liver transplant. It may help patients and teams find problems earlier using safer, easier monitoring.
This study looks at using a special lab test (microarrays) on tissue taken during a lung transplant biopsy. It aims to learn how the test may help doctors better diagnose and guide care after transplant.
This study checks how special lab tests on heart tissue samples can help guide diagnosis and treatment for people with a heart transplant. You may be eligible if you already need a heart tissue biopsy for a clinical reason and can provide consent.
This study looks at whether genetic testing of a tissue sample (biopsy) can help doctors more accurately diagnose rejection after a liver transplant. It is for people who have already been diagnosed with rejection and have a stored tissue sample available.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This study uses a tiny probe placed in the new liver during transplant surgery to monitor its health in real time. It may help doctors detect problems early and improve recovery after transplant.
Hear when a new Liver Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.